Related Experiment Video
Updated: May 14, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Seventh Åland Island Meeting on von Willebrand Disease
Riitta Lassila1, Ruben Bierings2, Nathan T Connell3
1Coagulation Disorders Unit, Department of Haematology, and the Research Program of Systems Oncology, HUS Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Introduction:
The seventh Åland Island Meeting on von Willebrand Disease (VWD) was held on the Åland archipelago in Finland, from 26 to 28 September 2024.
Aim:
The meeting brought together experts in the field of VWD from around the world to share the latest advances and knowledge in VWD.
Results And Discussion:
The topics covered both clinical aspects of management and biochemical and laboratory insights into the disease. The clinical topics discussed included epidemiology of VWD, the diagnostic landscape and treatment strategies. Special attention was paid to the challenges of VWD in women and to the definition of disease severity, both key areas of ongoing clinical debate. Emerging research in bleeding disorders was also highlighted. Much has been achieved in the diagnosis and treatment of VWD, and the outlook is positive for people with VWD, who can expect continued improvements in their care in the coming years. To ensure optimal translation of increased understanding to improved care of people with VWD, a multidisciplinary approach with biochemists, geneticists and cell biologists partnering with clinicians and industry is needed.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Rheumatic Heart Disease III: Medical Management

